We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
FCDO travel advice for São Tomé and Príncipe. Includes safety and security, insurance, entry requirements and legal differences.
Before you travel No travel can be guaranteed safe. Read all the advice in…
This information is for people travelling on a full ‘British citizen’…
Terrorism There is a high threat of terrorist attack globally affecting UK…
Before you travel check that: your destination can provide the healthcare…
The Foreign, Commonwealth & Development Office (FCDO) cannot provide…
FCDO travel advice for Colombia. Includes safety and security, insurance, entry requirements and legal differences.
Your travel insurance could be invalidated if you travel against advice…
This section has safety advice for regions of Colombia. It only covers…
As with all products, the MHRA will keep its safety under close review.
There are changes to the legislation on reference medicinal products (RMPs) used to support abridged marketing authorisation applications.
Reported problems with the supply of an animal medicine and the date when the issue is expected to be resolved.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Guidance for Applicants wishing to apply for a Promising Innovative Medicines designation, pre-submission meeting or an EAMS Scientific Opinion.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
The Commission on Human Medicines (CHM) advises ministers on the safety, efficacy and quality of medicinal products. CHM is an advisory non-departmental public body, sponsored by the Department of Health and Social Care .
Criteria applied by the VMD for accepting and agreeing the invented name of veterinary medicinal products.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).